Pipettes take small molecule inhibitors from discovery to clinical trials
INTEGRA Biosciences supplies RAPT Therapeutics in San Francisco, USA, with pipettes to accelerate the development of its candidate small molecule inhibitors for the treatment of inflammatory diseases and cancers